[HTML][HTML] Statins and peripheral arterial disease: a narrative review

S Jansen-Chaparro, MD López-Carmona… - Frontiers in …, 2021 - frontiersin.org
Peripheral arterial disease (PAD) is a highly prevalent atherosclerotic condition. In patients
with PAD, the presence of intermittent claudication leads to a deterioration in quality of life. In …

Hyperbaric oxygen therapy and vascular complications in diabetes mellitus

I Resanović, B Zarić, J Radovanović… - …, 2020 - journals.sagepub.com
Vascular complications in patients with diabetes mellitus (DM) are common. Since impaired
oxygen balance in plasma plays an important role in the pathogenesis of chronic DM …

Association between serum uric acid levels and peripheral artery disease in Chinese adults with hypertension

F Han, C Yu, F Hu, W Zhou, T Wang, L Zhu… - Frontiers in …, 2023 - frontiersin.org
Background Higher serum uric acid (SUA) can cause gout, which is principally characterized
by arthritis due to monosodium urate crystal deposition in the lower extremities. High levels …

Candesartan protects against unilateral peripheral limb ischemia in type-2 diabetic rats: possible contribution of PI3K-Akt-eNOS-VEGF angiogenic signaling pathway

S Khaled, RR Abdelaziz, GM Suddek… - International …, 2023 - Elsevier
Abstract Type-2 diabetes (T2DM) is known to be highly associated with increased risk for
vascular complications including peripheral arterial diseases (PAD). Critical limb ischemia …

Use of statins in patients with peripheral artery disease

E Corrado, A Mignano, G Coppola - Trends in Cardiovascular Medicine, 2020 - Elsevier
Atherosclerotic peripheral artery disease (PAD) is a growing health issue that affects more
than 200 million individuals worldwide, conferring a high risk of cardiovascular events and …

Increased risk of developing peripheral artery disease in hemodialysis patients receiving statin treatments: a population-based cohort study in Taiwan

YH Hsu, FC Sung, CH Muo, SY Chuang… - Nephrology Dialysis …, 2020 - academic.oup.com
Background Few investigations have evaluated the influences on peripheral arterial disease
(PAD) risk of statin treatment in hemodialysis (HD) subjects with hyperlipidemia (HL) …

Forty‐eight weeks of statin therapy for type 2 diabetes mellitus patients with lower extremity atherosclerotic disease: Comparison of the effects of pitavastatin and …

X Zhou, L Wu, Y Chen, H Xiao, X Huang… - Journal of Diabetes …, 2021 - Wiley Online Library
Abstract Aims/Introduction Type 2 diabetes mellitus is correlated with systemic
atherosclerosis. Statin therapies have been proved to reduce low‐density lipoprotein …

Impact of ACEi/ARB discontinuation after an episode of hyperkalemia in patients with Chronic Kidney Disease. A Population-Based Cohort Study

SJ Leon Mantilla - 2020 - mspace.lib.umanitoba.ca
Background: Angiotensin-converting-enzyme inhibitors (ACEi) and angiotensin II receptor
blockers (ARB) are recommended in diabetic and proteinuric nondiabetic chronic kidney …

The peripheral arterial disease pandemic: no let-up in sight

DG Hackam - The Canadian journal of cardiology, 2021 - pubmed.ncbi.nlm.nih.gov
The Peripheral Arterial Disease Pandemic: No Let-up in Sight The Peripheral Arterial
Disease Pandemic: No Let-up in Sight Can J Cardiol. 2021 Oct;37(10):1496-1497. doi …

[引用][C] Contrasting Trends in Vascular Amputations: Progress or Peril?

DG Hackam - The Canadian journal of cardiology, 2023 - pubmed.ncbi.nlm.nih.gov